Exploring the impact of open innovation on firm performances
Summary. This study examines how open innovation practices affect firm performance in bio-pharmaceutical companies. Analyzing 110 major R&D spenders from 2008-2012, the researchers found that increased openness reduces R&D productivity and patent revenue ratios, but boosts sales growth. Operating profit shows an inverted U-relationship with inbound innovation and a U-shape with outbound innovation. The findings reveal that openness produces mixed financial and innovation outcomes, requiring managers to carefully balance collaborative innovation strategies.
Cite this article
Caputo, M., Lamberti, E., Cammarano, A., & Michelino, F.. (2016). Exploring the impact of open innovation on firm performances. Management Decision. https://doi.org/10.1108/md-02-2015-0052
Caputo, Mauro, et al. “Exploring the impact of open innovation on firm performances.” Management Decision, 2016. https://doi.org/10.1108/md-02-2015-0052.
Caputo, Mauro, Emilia Lamberti, Antonello Cammarano, and Francesca Michelino. 2016. “Exploring the impact of open innovation on firm performances.” Management Decision. https://doi.org/10.1108/md-02-2015-0052.
@article{caputo-2016-exploring-impact-open-innovation-firm,
title = {Exploring the impact of open innovation on firm performances},
author = {Mauro Caputo and Emilia Lamberti and Antonello Cammarano and Francesca Michelino},
journal = {Management Decision},
year = {2016},
doi = {10.1108/md-02-2015-0052},
url = {https://doi.org/10.1108/md-02-2015-0052}
}
TY - JOUR TI - Exploring the impact of open innovation on firm performances AU - Mauro Caputo AU - Emilia Lamberti AU - Antonello Cammarano AU - Francesca Michelino JO - Management Decision PY - 2016 DO - 10.1108/md-02-2015-0052 UR - https://doi.org/10.1108/md-02-2015-0052 ER -
Details
- DOI
- 10.1108/md-02-2015-0052
- Countries
- Italy
- Regions
- Europe
- Categories
- innovation-theory, innovation-networks, general-innovation
- Added
- 2026-04-28